Telemonitoring for the Recuperation of Patients With CPAP

NCT ID: NCT04297163

Last Updated: 2021-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-11-01

Study Completion Date

2021-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed at patients who do not achieve a minimum (≥4 hours/night) or optimal (≥5,5 hours/night) use of Continuous Positive Airway Pressure (CPAP) treatment and it is proposed to improve their adherence making a 4-weeks intervention using telemedicine tools: CPAP remote monitoring, a mobile application (app) and a voicemail. The concept of this work is to "recover" patients to minimum or optimal CPAP use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Given the prevalence of Obstructive Sleep Apnea (OSA), the symptoms it produces, which is a risk factor for various entities and that, in addition, its treatment clearly improves others; its control must be optimized in an effective and cost-effective manner. The use of information and communication technologies (ICT) in this context can be very beneficial.

The design of the study is prospective, randomized, controlled, open and parallel.

A ICT-based out of hospital management of OSA is implemented to be compared with the classical in-hospital management.

The main objectives were to evaluate the effectiveness of of two OSA management programs: the in-hospital classic management versus a telemedicine program based on the use of ICTs in the recovery of patients with OSA who who do not meet the minimum treatment (4 hours) or in those who do not comply with the optimal use (5.5 hours).

This is a 4-weeks management randomized, with parallel groups study. Participants will be patients from the Sleep Unit of Hospital Clinic Barcelona with OSA diagnosis and CPAP treatment indication, who after a follow-up between 3-months and up to 5 years have a CPAP compliance below 5,5 hours/night.

Two management programs will be compared:

* In-hospital classic management: Patients are followed regularly in the hospital with a face-to-face visit by the Sleep unit nurse.
* Telemedicine management: telemedicine support with mobile app, voicemail and CPAP remote monitoring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Apnea, Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

4-weeks randomized with parallel groups study.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospital management

Patient's receive no intervention, the follow up is the usual for a patient following CPAP therapy.

Group Type ACTIVE_COMPARATOR

In Hospital

Intervention Type OTHER

Face-to-face follow up

Telemedicine management

CPAP remote monitoring of patients, including a mobile application and a voicemail.

Group Type EXPERIMENTAL

Telemedicine

Intervention Type OTHER

Remote CPAP monitoring, mobile app and voice mail

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telemedicine

Remote CPAP monitoring, mobile app and voice mail

Intervention Type OTHER

In Hospital

Face-to-face follow up

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years,
* CPAP treatment initiated ≥1 month and \<12 months
* CPAP compliance below 5.5 hours per night,
* Regular use of Smartphone and mobile apps.

Exclusion Criteria

* Clinical suspicion or other confirmed sleep pathology,
* Severe nasal obstruction that prevents the use of CPAP,
* Physical-psychological inability to follow questionnaires and the program,
* Patients undergoing uvulopalatopharyngoplasty,
* Cheyne-Stokes syndrome,
* Pregnancy,
* Rejection in the initial test with CPAP during the training and education session and
* Failure to obtain informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Salud Carlos III

OTHER_GOV

Sponsor Role collaborator

Hospital Clinic of Barcelona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose M. Montserrat

Pneumologist consultor senior

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Josep M Montserrat, Prof

Role: STUDY_DIRECTOR

Hospital Clinic/Universitat de Barcelona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Josep M Montserrat Canal

Barcelona, Catalonia, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Josep M Montserrat, Prof

Role: CONTACT

932275746

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Monique C Suarez Giron, MD PhD

Role: primary

932275746 ext. 5746

Onintza Garmendia, MsC

Role: backup

932275746 ext. 5746

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI17/01068

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.